These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30238807)

  • 1. Pharmacogenomics/updated for precision medicine in dermatology.
    Do LHD; Maibach H
    J Dermatolog Treat; 2019 Jun; 30(4):410-413. PubMed ID: 30238807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
    Daneshjou R; Huddart R; Klein TE; Altman RB
    Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.
    Rizzo AE; Maibach HI
    J Dermatolog Treat; 2012 Jun; 23(3):161-7. PubMed ID: 21254882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in dermatology: Taking patient treatment to the next level.
    Schweitzer J; Maibach H
    J Dermatolog Treat; 2015 Feb; 26(1):94-6. PubMed ID: 24552417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How pharmacogenomics of biological response modifiers will influence clinical response and toxicity in dermatology.
    Dalle S; Thomas L; Shear NH
    Int J Dermatol; 2011 Jan; 50(1):114-8. PubMed ID: 21182511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.
    Pincelli C; Pignatti M; Borroni RG
    Exp Dermatol; 2009 Apr; 18(4):337-49. PubMed ID: 19348000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling.
    Schuck RN; Grillo JA
    AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.
    Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Abad-Santos F; Daudén E
    Am J Clin Dermatol; 2018 Apr; 19(2):209-222. PubMed ID: 28921458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of drug information: FDA-approved labeling and other official FDA sources.
    Lindstrom JA
    Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Web-Based Pharmacogenomics Search Tool for Precision Medicine in Perioperative Care.
    Zarei S; Costas Y; Orozco G; Zaydlin M; Mirtar A; Abouali M; Diaz-Marty C; Akhlaghipour G; Fernandez Altamirano P; Gonzalez Cardona AR; Reiley LE; Mirzakhani H
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32708157
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles in dermatology.
    Papakostas D; Rancan F; Sterry W; Blume-Peytavi U; Vogt A
    Arch Dermatol Res; 2011 Oct; 303(8):533-50. PubMed ID: 21837474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics: Principles and Relevance to Oncology Nursing
.
    Dodson CH
    Clin J Oncol Nurs; 2017 Dec; 21(6):739-745. PubMed ID: 29149126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.
    Payami H
    Mov Disord; 2017 Aug; 32(8):1139-1146. PubMed ID: 28686320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
    Shu WY; Li JL; Wang XD; Huang M
    Acta Pharmacol Sin; 2015 May; 36(5):535-43. PubMed ID: 25891088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.